IL10 and COVID-19: IL-27 is an anti-inflammatory cytokine that activates Th1 cells and natural killer cells, inhibits Th2 and Th17 cells, and stimulates release of IL-10 by T cells, and has been reported as a reliable predictor of adverse outcomes and mortality in COVID-19 (42–45).